糞鈣衛蛋白檢測全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球糞鈣衛蛋白檢測市場預計將從2025年的51.4億美元成長至2034年的141.2億美元，2026年至2034年的複合年成長率（CAGR）為11.89%。隨著醫療專業人員日益重視胃腸道疾病的早期檢測和後續觀察，糞便鈣衛蛋白檢測市場正蓬勃發展。鈣衛蛋白是一種腸道發炎生物標記物，擴大用於診斷發炎性腸道疾病（IBD）、克隆氏症、潰瘍性大腸炎和其他疾病。隨著全球慢性胃腸道疾病負擔的加重，對可靠且非侵入性的檢測方法的需求預計將進一步成長。

技術進步正在提高診斷的準確性和效率。即時檢測套組能夠快速提供結果，從而提高患者依從性並支持及時制定治療方案。自動化免疫檢測和酵素連結免疫吸附試驗（ELISA）平台簡化了檢查室工作流程，而數位資料管理則將檢測結果與電子健康記錄整合在一起。這些進步正在改善全球醫療保健系統的臨床療效和營運效率。

未來市場擴張將受個人化醫療和預防醫學的影響。隨著臨床醫生擴大採用基於生物標記的疾病管理方法，糞便鈣衛蛋白檢測將在減少大腸鏡檢查等侵入性操作方面發揮關鍵作用。新興經濟體預計將迎來顯著成長，這得益於公眾意識的提高和醫療基礎設施的不斷改善。創新和可近性的提升推動了此檢測技術的普及，使其在全球診斷領域佔據重要地位。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球糞便鈣衛蛋白檢測市場：依檢測方法分類

• 市場分析、洞察與預測
• 酵素免疫分析法（ELISA）
• 酵素螢光免疫分析
• 定量層析法

第5章：全球糞便鈣衛蛋白檢測市場：依應用分類

• 市場分析、洞察與預測
• 發炎性腸道疾病
• 結腸癌
• 其他

第6章：全球糞便鈣衛蛋白檢測市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 學術研究機構

第7章：全球糞便鈣衛蛋白檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BUHLMANN Laboratories
  • Thermo Fisher Scientific
  • DiaSorin
  • BioMerieux
  • Roche Diagnostics
  • Siemens Healthineers
  • Eurofins Scientific
  • Abbott
  • Fujirebio
  • R-Biopharm
  • ScheBo Biotech
  • Buhlmann FCAL Turbo
  • Calpro AS
  • Immundiagnostik
  • Eagle Biosciences

The global faecal calprotectin testing market size is expected to reach USD 14.12 Billion in 2034 from USD 5.14 Billion in 2025, growing at a CAGR of 11.89% during 2026-2034.The faecal calprotectin testing market is gaining momentum as healthcare providers emphasize early detection and monitoring of gastrointestinal diseases. Calprotectin, a biomarker of intestinal inflammation, is increasingly used in diagnosing conditions such as inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. With the global burden of chronic digestive disorders on the rise, demand for reliable, non-invasive testing methods is expected to accelerate.

Technological progress is enhancing diagnostic accuracy and efficiency. Point-of-care testing kits are enabling rapid results, improving patient compliance, and supporting timely treatment decisions. Automated immunoassays and ELISA platforms are streamlining laboratory workflows, while digital data management is integrating test results with electronic health records. These advancements are improving both clinical outcomes and operational efficiency for healthcare systems worldwide.

Future market expansion will be shaped by personalized medicine and preventive healthcare. As clinicians increasingly adopt biomarker-based approaches for disease management, faecal calprotectin testing will play a crucial role in reducing invasive procedures such as colonoscopy. Emerging economies are expected to witness significant growth, supported by rising awareness and expanding healthcare infrastructure. With innovation and accessibility driving adoption, this testing market is positioned as a vital component of the global diagnostic landscape.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Assay

• Enzyme-linked Immunosorbent Assay
• Enzyme Fluroimmunoassay
• Quantitative Immunochromatography

By Application

• Inflammatory Bowel Disease
• Colorectal Cancer
• Others

By End-use

• Hospitals And Clinics
• Diagnostic Laboratories
• Academic And Research Institutes

COMPANIES PROFILED

• BUHLMANN Laboratories, Thermo Fisher Scientific, DiaSorin, bioMerieux, Roche Diagnostics, Siemens Healthineers, Eurofins Scientific, Abbott, Fujirebio, R-Biopharm, ScheBo Biotech, Buhlmann fCAL turbo, Calpro AS, Immundiagnostik, Eagle Biosciences

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Assay
• 4.2. Enzyme-linked Immunosorbent Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzyme Fluroimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Quantitative Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Inflammatory Bowel Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FAECAL CALPROTECTIN TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Assay
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Assay
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Assay
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Assay
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Assay
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FAECAL CALPROTECTIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BUHLMANN Laboratories
  • 9.2.2 Thermo Fisher Scientific
  • 9.2.3 DiaSorin
  • 9.2.4 BioMerieux
  • 9.2.5 Roche Diagnostics
  • 9.2.6 Siemens Healthineers
  • 9.2.7 Eurofins Scientific
  • 9.2.8 Abbott
  • 9.2.9 Fujirebio
  • 9.2.10 R-Biopharm
  • 9.2.11 ScheBo Biotech
  • 9.2.12 Buhlmann FCAL Turbo
  • 9.2.13 Calpro AS
  • 9.2.14 Immundiagnostik
  • 9.2.15 Eagle Biosciences